Good morning :)
Place Order
Add to Watchlist

Concord Drugs Ltd

CONCORD

Concord Drugs Ltd

CONCORD
Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,806
High RiskStock is 3.50x as volatile as Nifty
37.040.00% (+0.00)
37.040.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,806
High RiskStock is 3.50x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,806
High RiskStock is 3.50x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-71.231.10
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.706.650.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Concord Drugs is a pharmaceutical company, engaged in the manufacture of pharmaceutical formulations and the trading of packing material

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2022FY 2023FY 2024TTM
Total Revenue59.0652.0944.9352.48
Raw Materialssubtract44.4141.1631.1049.79
Power & Fuel Costsubtract0.000.000.00
Employee Costsubtract4.143.845.00
Selling & Administrative Expensessubtract1.532.142.06
Operating & Other expensessubtract3.280.362.73
Depreciation/Amortizationsubtract1.761.631.561.46
Interest & Other Itemssubtract1.681.711.871.92
Taxes & Other Itemssubtract0.650.260.16-0.17
EPS1.841.100.47-0.52
DPS0.000.000.000.00
Payout ratio0.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Concord Drugs Ltd82.311.10
Sun Pharmaceutical Industries Ltd45.466.490.74%
Mankind Pharma Ltd64.6712.92
Cipla Ltd28.924.450.88%

Price Comparison

Compare CONCORD with any stock or ETF
Compare CONCORD with any stock or ETF
CONCORD
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.01%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.01%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding54.39%0.00%0.00%0.00%45.61%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepOctDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

CONCORD has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Concord Drugs consolidated net profit declines 92.86% in the September 2024 quarter

Net profit of Concord Drugs declined 92.86% to Rs 0.04 crore in the quarter ended September 2024 as against Rs 0.56 crore during the previous quarter ended September 2023. Sales rose 64.36% to Rs 12.36 crore in the quarter ended September 2024 as against Rs 7.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.367.52 64 OPM %7.1221.41 - PBDT0.411.19 -66 PBT0.070.80 -91 NP0.040.56 -93 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales rose 30.18% to Rs 11.69 crore in the quarter ended June 2024 as against Rs 8.98 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales11.698.98 30 OPM %7.1016.26 - PBDT0.381.02 -63 PBT0.040.64 -94 NP0.030.49 -94 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Concord Drugs standalone net profit rises 7.14% in the December 2022 quarter

1 year agoBusiness Standard

Stocks that will see action on September 9, 2022

2 years agoThe Hindu Businessline

Concord Drugs standalone net profit rises 475.00% in the September 2021 quarter

3 years agoBusiness Standard